RNAi Tools and Therapeutics Market Analysis and Business Tutorial
Select Biosciences welcomes you to attend a half day interactive market analysis and Business tutorial presented by Enal Razvi, Ph.D.
This market analysis tutorial will be held immediately after the RNAi 2008 Europe Conference. Attendees will have the opportunity of acquiring the Select Biosciences RNAi Therapeutics 2008 Market Report as part of the delegate package. The package represents a considerable saving over normal list price. Please click the Registration tab on the left-hand side for various pricing options.
Introduction to the Tutorial
This market analysis and business tutorial is designed to provide a complete overview and analysis of the RNAi Research Tools and RNAi Therapeutics markets. The RNAi tools space is maturing and evolving and Select Biosciences presents an update from it’s continuing research coverage of this space. RNAi-based Therapeutics is only just beginning and we has been tracking this space from the beginning. The tutorial will present the market landscape in qualitative and quantitative terms and more specifically present market analysis from market surveys that we continuously perform as part of our continuing industry coverage of these spaces. All materials presented will be provided on CD. In addition, you can choose to increase the value of your trip by pre-ordering the latest report at a substantial saving versus normal price. This is a fast-paced business-focused tutorial, which will include a round-table discussion with your fellow attendees.
Topics Covered in this Tutorial
- Technology Overview of the broader RNAi Space
- RNAi in the Research Tools Space—Qualitative and Quantitative Market Trends based on End-User Market Surveys
- SWOT Analysis of the Marketplace
- Niches of Market Opportunity
- RNAi-based Therapeutics Landscape
- Technology Trends
- RNAi-based Therapeutics: Intellectual Property (IP) Status Update
- Companies in the RNAi Therapeutics Space and Their Current Therapeutics Pipeline—From Research/Preclinical to Phase III Clinical Trials
- Drug Targets amenable to RNAi-based Therapeutics
- New Entrants and Select Biosciences SWOT Analysis of Each Company in the Space
Who Should Attend
• Scientists in Pharmaceutical and Biotechnology companies
• Business Development Executives in Pharmaceutical and Biotechnology companies
• Representatives from Academic Institutions
• Established and start-up companies in RNAi space (tools or therapeutics) and vendors currently offering or seeking to offer products into these spaces
• Venture Capital community and investors seeking to understand these markets, and associated business opportunities and intellectual property landscape
Learning Objectives/Themes
• Overview of the market landscape in the RNAi tools and therapeutics markets—these are fast-moving and evolving spaces and Select Biosciences’ analysis is up-to-date and complete
• Market analysis and quantitative trends
• Emerging business opportunities, and associated challenges
• Review of the various technologies in these spaces
• Interactive round table moderated discussion